Talk:Epic Sciences

unsourced
The following is unsourced and was moved here per WP:PRESERVE. Per WP:BURDEN please do not restore without finding independent, reliable sources, checking the content against them, and citing them, and ensuring that this content has appropriate WP:WEIGHT in the article overall.

Dr. Nelson was CEO from 2010 until July 2013. During that time, the Epic team industrialized the academic technology from the Kuhn lab, established numerous academic collaborations (Memorial Sloan Kettering, Moffitt, MD Anderson, Royal Marsden, Yale etc.), received multiple grants from the National Cancer Institute, signed collaborations with over 10 pharmaceutical companies for many clinical studies including over 3000 patients, closed two rounds of private equity financing with top tier investors (Domain Associates, Roche, and Pfizer), executed a partnership with LabCorp to provide global reach, partnered with Microsoft to provide innovative and scalable computational solutions, and initiated a business strategy to pursue both independent diagnostic products as well as companion diagnostics with its pharmaceutical partners.

--Jytdog (talk) 17:22, 28 June 2017 (UTC)